Zhejiang Shapuaisi Pharmaceutical (603168.SH): Olodaterol hydrochloride eye drops obtained drug registration certificate

25/02/2025

GMT Eight

Zhejiang Shapuaisi Pharmaceutical (603168.SH) announced that the company has received the Drug Registration Certificate for Olopatadine Hydrochloride Eye Drops approved and issued by the National Medical Products Administration. The approved Olopatadine Hydrochloride Eye Drops are used to treat eye itching related to allergic conjunctivitis.

TRIP.COM-S(09961): Can inbound tourism withstand the high investment and turn the tide?

Tibet Weixinkang Pharmaceutical (603676.SH) obtained the drug registration certificate for Compound Amino Acid Injection (18AA-).

Contact: contact@gmteight.com

Zhejiang Shapuaisi Pharmaceutical (603168.SH): Olodaterol hydrochloride eye drops obtained drug registration certificate

RECOMMEND

Yang Jianxin, the largest shareholder of Global Top E-Commerce (002640.SZ), with a 2.3% stake in the company, will have his shares auctioned off by the courts.

AAC TECH spent 13.86 million Hong Kong dollars on February 25 to repurchase 291,500 shares.

Hangzhou Freely Communication(603602.SH): Pu Shu completed the reduction of 0.87% of shares.